Project Number 5R01AG044332-05 Agency/Funding Organization NIA Funding Year 2017 View Full Project Details for Orally-absorbed, small molecule microtubule-stabilizers for tauopathy treatment Research Categorization Primary Disease / Condition Alzheimer's Disease Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator BRUNDEN, KURT R. Principal Investigator First Name KURT R. Principal Investigator Last Name BRUNDEN Awardee Organization UNIVERSITY OF PENNSYLVANIA Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-10-001: DRUG DISCOVERY FOR NERVOUS SYSTEM DISORDERS (R01) FY Overall Cost $455,558 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO Related Resources Patent Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathies
